News

Novo Nordisk teams with NBA’s Dominique Wilkins to launch Dominique’s Diabetes Dream Team

BY Michael Johnsen

PLAINSBORO, N.J. — Novo Nordisk is teaming up with NBA Hall of Famer Dominique Wilkins to launch Dominique’s Diabetes Dream Team, a national initiative to help adults with Type 2 diabetes customize a "full-court" approach to managing the everyday challenges of the disease.

Dominique’s Diabetes Dream Team will highlight three key components of a successful diabetes management plan: a balanced diet, regular exercise and proper medication, as needed. Dominique’s own team is comprised of his physicians, a diabetes educator, a nutritionist and a fitness expert, who together offer him guidance on daily diabetes management.

"Diabetes is a complex disease, and it takes a team to get the best results. When I was diagnosed with the disease, I formed my own ‘Diabetes Dream Team,’" Wilkins said. "They’ve taught me that small, simple changes can make a big difference, and I am excited to partner with Novo Nordisk to help others think differently about managing their diabetes."

Adults with Type 2 diabetes can visit DiabetesDreamTeam.com to download a copy of Dominique’s "Diabetes Coaches’ Clipboard." The clipboard is full of insider tips on diabetes management from Dominique and his team of experts.

Dominique also will be in attendance at select diabetes conferences nationwide, where he and his team will share personal stories and advice on how people can better manage their diabetes with the help of their own Diabetes Dream Team.

"The way Dominique has learned to manage his Type 2 diabetes sets a good example for anyone living with the disease," said Camille Lee, SVP diabetes marketing at Novo Nordisk. "Novo Nordisk wants to share his success to benefit others who face daily struggles with Type 2 diabetes." 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Report: Pharmaceutical sales to grow 5.1% on average through 2020

BY Michael Johnsen

LONDON — Worldwide prescription drug sales are expected to exceed the trillion dollar mark by 2020, according to Evaluate's "World Preview 2014, Outlook to 2020" report released Wednesday. Evaluate projects the pharma industry to grow, on average, 5.1% per year from 2013 to 2020. 

Biologicals will make up 52% of the top 100 prescription and OTC drug sales in 2020, Evaluate reported. Oncology will set record high growth with an 11.2% compound annual growth rate to 2020. Novartis is expected to remain the top company by global drug sales in 2020, Evaluate reported. Teva Pharmaceuticals was the leading generic drug maker in 2013. 

“This much improved growth outlook comes as welcome news after two years of actual sales stagnation,” stated Paul Hills, report author and Evaluate’s head of operations. “While the patent cliff is now but a distant memory, a new debate over drug pricing is stirring up controversy. This will only intensify as the industry continues to shift away from primary care and new technology waves offer innovative products that potentially take costs out of healthcare.”

The “World Preview 2014, Outlook to 2020” report, based on market intelligence and consensus forecasts from EvaluatePharma, can be downloaded at Evaluategroup.com/wp2014, the company stated. 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Cardinal Health enhances cardiovascular tools available to retail pharmacy

BY Michael Johnsen

DUBLIN, Ohio — Cardinal Health on Wednesday outlined a number of enhanced tools to make it easier for retail pharmacies to help their patients better manage their cardiovascular health and prevent heart disease.

“As payers place an increasing emphasis on improving their performance on Medicare’s Star Ratings System, they’ll increasingly look to retail pharmacies to deliver services that help patients better manage cardiovascular risks and improve their overall heart health,” stated Brad Tice, product leader for Cardinal Health’s Medication Therapy Management Solution. “We’re excited to introduce these enhanced services, which will make it easier than ever before for community pharmacists to deliver heart health services to patients and to market these valuable services to physicians, employers and payers.” 

Retail pharmacies that utilize Cardinal Health’s Specialized Care Center focused on Heart Health already have access to training, patient education, marketing tools, product and merchandising recommendations that help position them as a local destination for cardiovascular health needs.

Now, pharmacies that utilize Cardinal Health’s Heart Health Specialized Care Center also have access to:

  • My Digital Health Coach patient tracking and reporting tools;
  • New resources to make it easier to screen patients for cardiovascular risks;
  • New continuing education courses to enhance their knowledge about effective strategies for improving heart health;
  • Discounts on non-prescription products that patients with cardiovascular conditions need, like home diagnostics and pain relief products, vitamins and specialty supplements;
  • New print and electronic marketing tools to educate local physicians and employers about how community pharmacists can help patients prevent heart disease and improve heart health; and
  • New print and electronic promotional materials to market their heart health services to patients.

 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?